COVID-19 was a disease caused by a new coronavirus, SARS-CoV-2, that spread around the world from early 2020 and changed daily life almost everywhere. Its story has three parts: how the virus spread, how science fought back, and the harms that lingered after the emergency. The hardest lesson was that the true cost turned out far larger than official counts showed, and much of it came from things other than the virus itself.
How Many People Died
By the end of 2021, countries had reported about 5.4 to 5.9 million COVID-19 deaths.1PubMed Central. The WHO estimates of excess mortality associated with the COVID-19 pandemic Counting “excess deaths”, the extra deaths beyond what a normal year would bring, gives a much larger figure: about 14.8 million for 2020 and 2021.2PubMed Central. The WHO estimates of excess mortality associated with the COVID-19 pandemic Another major estimate put excess deaths at about 18.2 million by the end of 2021, roughly 3 times the reported number.3PubMed Central. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21 That works out to about 120 extra people dying for every 100,000 people on Earth.4PubMed Central. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21
Reported deaths missed so many for a few reasons. Many people died without ever being tested, especially early on and in poorer countries. Others died because hospitals were overwhelmed and care for heart attacks, cancer and other illnesses was delayed. Extra deaths sidestep arguments over what belongs on a death certificate by comparing the number of people who died with the number expected.
The second year was far worse, with about 10.4 million extra deaths in 2021 against 4.5 million in 2020.5PubMed Central. The WHO estimates of excess mortality associated with the COVID-19 pandemic More contagious versions of the virus spread widely in 2021. Vaccines arrived, but many countries received them late. And the virus reached places it had largely missed in 2020.
How the Virus Spread
The virus spread mainly through aerosols, tiny particles a person breathes out that can float in room air.6PubMed Central. A guideline to limit indoor airborne transmission of COVID-19 Airborne spread is now thought to be the main route for several respiratory viruses, not just this one.7Science. Airborne transmission of respiratory viruses Superspreading events, where one person infected many, happened mostly indoors.8PubMed Central. A guideline to limit indoor airborne transmission of COVID-19
In daily life, that meant crowded, poorly ventilated rooms such as choir practices, bars and gyms were high risk. Outdoor gatherings were much safer because air disperses the particles. Opening windows and improving ventilation lowered indoor risk. Six feet of distance helped less indoors, where the air could sit still for hours.
Early advice focused on surfaces, with people wiping down groceries and handrails. Handwashing is still useful, but surfaces turned out to be a minor route.
Once inside the body, the virus’s spike protein latches onto a doorway on cells. That doorway sits in the nose, lungs, heart, gut and blood vessels, and its wide spread helps explain why COVID could affect so many organs.
People who never developed symptoms could still spread it, but less. About 1 in 100 household and close contacts of people who never developed symptoms caught the virus.9PubMed Central. The role of asymptomatic and pre-symptomatic infection in SARS-CoV-2 transmission—a living systematic review For contacts of people with symptoms, or about to get them, about 6 to 7 in 100 were infected.10PubMed Central. The role of asymptomatic and pre-symptomatic infection in SARS-CoV-2 transmission—a living systematic review People are often most contagious in the day or two before symptoms start. So someone feeling well before getting sick spread it about as much as someone already ill.11PubMed Central. Transmission risk of asymptomatic SARS-CoV-2 infection: a systematic review and meta-analysis
New Variants and Why They Mattered
A variant is a new version of the virus with changes, often in the spike protein the body learns to recognise.12PubMed Central. Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far? Alpha, the first worrying variant, was still mostly blocked by antibodies from vaccines and past infection, though somewhat less.13PubMed Central. Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far? Beta weakened antibody protection more.14PubMed Central. Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far? Omicron versions carried more than 15 changes in the key part of the spike.15PubMed Central. SARS-CoV-2 variant biology: immune escape, transmission and fitness As a result, the original vaccines and pre-Omicron infections produced antibodies that blocked Omicron very poorly.16PubMed Central. SARS-CoV-2 variant biology: immune escape, transmission and fitness
These changes happen because each copy of the virus can carry small copying errors. More infections mean more copies, and so more chances for a useful change to arise. Changes that help the virus spread or dodge immunity take over, which is why vaccines were updated to newer strains.
The World Health Organization named variants Alpha, Beta, Gamma, Delta and Omicron to avoid stigmatising the countries where they were first found. Omicron offshoots such as BA.1 and BA.5 kept the family name.
What the Virus Did to the Body
In severe COVID, the immune system could release a flood of inflammatory signals.17PubMed Central. Cytokine storm associated coagulation complications in COVID-19 patients: Pathogenesis and Management This immune overreaction made blood vessels leaky, contributing to low blood pressure and failing lungs.18PubMed Central. The signal pathways and treatment of cytokine storm in COVID-19 It also raised the risk of dangerous blood clots.19PubMed Central. Cytokine storm associated coagulation complications in COVID-19 patients: Pathogenesis and Management Much of the damage in critical cases came from inflammation rather than the virus directly.
Most people never reached that point. They had a cold- or flu-like illness, and loss of taste and smell was a distinctive early symptom. Older age, obesity, diabetes and weakened immunity raised the risk of severe disease, and severe cases needed oxygen or ventilators.
How Well the Vaccines Worked
Protection against serious illness held up. Five months or more after vaccination against Delta, Pfizer’s vaccine still prevented about 92 in 100 hospitalisations and deaths.20PubMed Central. Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines AstraZeneca’s vaccine still prevented about 80 in 100 hospitalisations and 85 in 100 deaths at that point.21PubMed Central. Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines Protection against any symptomatic illness fell faster, especially in people 65 and older.22PubMed Central. Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines
Against Omicron, protection from infection faded quickly. Against Delta, protection from symptomatic illness lasted fairly well, with half of it gone after about 10 months.23JAMA Network Open. Evaluation of Waning of SARS-CoV-2 Vaccine–Induced Immunity: A Systematic Review and Meta-analysis Against Omicron, half was gone after about 3 months.24JAMA Network Open. Evaluation of Waning of SARS-CoV-2 Vaccine–Induced Immunity: A Systematic Review and Meta-analysis Protection from symptomatic Omicron fell from about 53% one month after the first doses to about 14% at six months.25JAMA Network Open. Evaluation of Waning of SARS-CoV-2 Vaccine–Induced Immunity: A Systematic Review and Meta-analysis The mRNA vaccines from Pfizer and Moderna started higher, near 60%, than AstraZeneca and Sinovac.26JAMA Network Open. Evaluation of Waning of SARS-CoV-2 Vaccine–Induced Immunity: A Systematic Review and Meta-analysis Boosters and updated shots were needed mainly to restore protection that waned and to match new variants.
The mRNA vaccines deliver a short genetic recipe for the spike protein inside tiny fat bubbles. Muscle cells near the injection make the spike briefly, and the immune system learns to recognise it. The fat bubbles also stir the immune system, which explains sore arms and tiredness. The recipe then breaks down and does not change your DNA.
Treatments That Helped
Paxlovid is an antiviral pill taken within 5 days of diagnosis.27Morbidity and Mortality Weekly Report. Paxlovid Associated with Decreased Hospitalization Rate Among Adults with COVID-19 — United States, April–September 2022 Adults prescribed it were about half as likely to be hospitalised within a month, even if already vaccinated.28Morbidity and Mortality Weekly Report. Paxlovid Associated with Decreased Hospitalization Rate Among Adults with COVID-19 — United States, April–September 2022 A large US health-records analysis found a smaller cut of about 39%, which was under 1 hospitalisation prevented per 100 people treated.29PubMed Central. Effect of nirmatrelvir/ritonavir (Paxlovid) on hospitalization among adults with COVID-19: An electronic health record-based target trial emulation from N3C So it helps most for people with a higher starting risk, such as older adults. If you are older or have health conditions and test positive, ask about it quickly, because the 5-day window is short.
Steroids helped the sickest. Dexamethasone, a cheap steroid, became a standard treatment for hospitalised patients.30PubMed. Dexamethasone in Hospitalized Patients with Covid-19 It calms the immune overreaction described earlier, and steroids prevented about 3 deaths per 100 patients treated.31PubMed. Systemic corticosteroids for the treatment of COVID-19 The benefit was clear for patients on ventilators or breathing masks, not for those needing only oxygen.32PubMed Central. The impact of dexamethasone on short- and long-term mortality in hospitalized COVID-19 patients: a retrospective study
Antivirals stop the virus copying itself early in illness. Steroids given too early may not help and can weaken useful defences.
Did Masks and Lockdowns Work
An expert review found lockdowns and masks both helped reduce transmission.33PubMed. Covid-19: Lockdowns and masks helped reduce transmission, expert group finds Mask rules appeared more effective than lockdowns or distancing alone, which fits airborne spread.34PubMed Central. A guideline to limit indoor airborne transmission of COVID-19 Masks alone stopped an outbreak only if nearly everyone wore highly effective ones.35PubMed Central. Effectiveness of face masks in reducing the spread of COVID-19: A model-based analysis With distancing in place, though, medium-quality masks worn by 8 in 10 people could shrink an outbreak.36PubMed Central. Effectiveness of face masks in reducing the spread of COVID-19: A model-based analysis
Quality mattered. Cloth masks blocked fewer airborne particles than surgical masks, and well-fitted N95-type respirators filtered the most. Gaps around the face let air leak past any mask.
Lockdowns slowed spread while vaccines were developed. They also caused isolation, lost income and school disruption.
Long COVID and Effects on Children
Long COVID is when symptoms continue for months after infection. Common symptoms include fatigue, crashes after exertion, brain fog, joint pain, tingling, and gut or eye problems.37PubMed Central. A review of cytokine-based pathophysiology of Long COVID symptoms People with long COVID show signs of ongoing inflammation and a worn-out immune system lasting beyond 6 months.38PubMed Central. Long COVID involves activation of proinflammatory and immune exhaustion pathways Tiny blood clots may also reduce blood flow to tissues.39PubMed Central. A review of cytokine-based pathophysiology of Long COVID symptoms The exact cause is still unclear and may include leftover virus or virus pieces.40PubMed Central. Pathophysiological, immunological, and inflammatory features of long COVID
Symptoms can come and go, and pushing through activity can trigger a crash a day or two later. Pacing activity is a common coping approach.
COVID was rarely severe in children.41PubMed Central. Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19 A small number, however, developed MIS-C, a rare severe inflammation of many organs, 2 to 6 weeks after infection.42PubMed Central. Post–COVID-19 multisystem inflammatory syndrome in children Signs include persistent fever, belly pain, vomiting, diarrhoea, rash, red eyes and headache.43PubMed Central. Post–COVID-19 multisystem inflammatory syndrome in children In one large US group, 8 in 10 needed intensive care, though most recovered.44PubMed Central. Multisystem Inflammatory Syndrome in Children (MIS-C) A child with ongoing fever and these symptoms weeks after a COVID illness needs urgent medical care.
MIS-C differs from ordinary COVID in kids because it appears weeks later, when the child may have seemed recovered. The child may test negative for the virus by then. It resembles Kawasaki disease and can affect the heart.
The Toll on Mental Health
Anxiety and depression rose by about 25% worldwide in the pandemic’s first year.45World Health Organization. COVID-19 pandemic triggers 25% increase in prevalence of anxiety and depression worldwide Isolation, fear of infection, grief and money worries all added stress.46World Health Organization. COVID-19 pandemic triggers 25% increase in prevalence of anxiety and depression worldwide Young people, women and poorer people were hit hardest.47PubMed Central. A systematic review of impacts of COVID-19 on depression and anxiety among general populations around the world Stricter lockdowns were often linked to more distress, especially where health services were weak.48PubMed Central. A systematic review of impacts of COVID-19 on depression and anxiety among general populations around the world
If low mood or anxiety lingers, it deserves a talk with a doctor. Effective treatments such as talking therapy exist, and loneliness can be eased by rebuilding regular contact.
Misinformation and Vaccine Doubt
People who believed false claims about vaccines were more hesitant and less willing to get vaccinated.49PubMed Central. Misinformation of COVID-19 vaccines and vaccine hesitancy Yet on Facebook, unflagged stories that leaned toward vaccine doubt had about 46 times more effect than flagged falsehoods.50PubMed. Quantifying the impact of misinformation and vaccine-skeptical content on Facebook Stories about rare deaths after vaccination were among the most viewed, though accurate.51PubMed. Quantifying the impact of misinformation and vaccine-skeptical content on Facebook In the US, doubts split sharply along political lines.52PubMed Central. Misinformation about vaccine safety and uptake of COVID-19 vaccines among adults and 5–11-year-olds in the United States
When you meet a scary vaccine headline, ask how rare the event is compared with the risk from COVID itself. A true single story can mislead about overall risk. It also helps to check whether health agencies investigated the claim.
Where It Came From and the Next Pandemic
Related coronaviruses from bats are estimated to infect tens of thousands of people in Southeast Asia every year.53PubMed Central. A strategy to assess spillover risk of bat SARS-related coronaviruses in Southeast Asia Another new coronavirus jumping to humans is a real possibility. In this pandemic, rich nations bought up early vaccine supplies, leaving many poorer countries waiting.54PubMed. What are the key features of an equitable global vaccine strategy for the next pandemic? A qualitative study of pandemic control experts Regions need their own vaccine making, approval and funding capacity built before the next crisis.55PubMed. What are the key features of an equitable global vaccine strategy for the next pandemic? A qualitative study of pandemic control experts
The origin of this virus remains unresolved. Most early cases were linked to Wuhan, China. Scientists debate natural spillover from animals versus a lab-related event, and no final conclusion has been reached.